Newsroom

Back
  • Newsroom
    • Research Newsroom
    • Contact a Media Specialist
    • B-roll Footage
    • Embargo Policy
    • Media Visitation Policy
    • Request to Film on Campus
    • Style Guide
    • Philanthropy Newsroom
    • Archived News

    UT MD Anderson honors visionary leadership of Dr. Peter Pisters following retirement announcement; shares transition plans

    August 26, 2026

    The University of Texas MD Anderson Cancer Center today is recognizing the exceptional leadership of Peter WT Pisters, M.D., president, following his announced plan to retire from UT MD Anderson to focus on the next chapter of his career. The UT System Board of Regents and Chancellor John M. Zerwas, M.D., have named Jeffrey E. Lee, M.D., interim president, effective immediately. Pisters will work with Lee on a thoughtful transition through...

    Read More

    Allison Institute announces appointment of four new members

    BY Clayton Boldt

    March 02, 2026

    The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the appointment of...

    Read More

    MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology

    BY Clayton Boldt

    January 07, 2026

    The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS...

    Read More

    Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer

    September 16, 2025

    62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse statement Nationally, HPV vaccination coverage has stagnated, falling short of national goals

    Today, The University of Texas MD Anderson Cancer Center, along with 61 National Cancer Institute (NCI)-Designated Cancer Centers, leading national organizations and the University of Puerto Rico Comprehensive...

    Read More

    MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

    BY Clayton Boldt

    September 05, 2025

    Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies Phoenix receives a supply of...
    Read More

    MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

    BY Clayton Boldt

    July 29, 2025

    3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies Teams will evaluate technology...
    Read More

    UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center

    BY Clayton Boldt

    May 14, 2025

    The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...

    Read More

    MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research

    BY Clayton Boldt

    March 25, 2025

    The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the Collaborative...

    Read More

    UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer

    BY Clayton Boldt

    February 19, 2025

    The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated...

    Read More

    MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

    BY Clayton Boldt

    January 07, 2025

    The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...

    Read More
    More

    Help #EndCancer

    Give Now

    Your gift will help make a tremendous difference.
    Donate

    Donate Blood

    Our patients depend on blood and platelet donations.

    Make an appointment

    Shop UT MD Anderson

    Show your support for our mission through branded merchandise. 

    View products
    Subscribe to our Cancerwise newsletter
    UT MD Anderson logoUT MD Anderson logo
    • Explore
    • Patients & Family
    • Prevention & Screening
    • Donors & Volunteers
    • For Physicians
    • Research
    • Education & Training
    • Clinical Trials
    • Languages
    • About
    • About UT MD Anderson
    • Careers
    • Blog
    • Newsroom
    • Editorial Standards
    • For Employees
    • Merchandise
    • Title IX Reporting (Sexual Misconduct)
    • Price Transparency
    • Finding Your Way
    • Our Doctors
    • Locations
    • Directions
    • Sitemap
    • DIGITAL ACCESSIBILITY
    • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
    • GET IN TOUCH
    • Call
      1-877-632-6789
    • Ask a question
    • Stay Connected
    • Cancerwise Podcast
    • More
    • Website Privacy Policy
    • Legal Statement & Policies
    • Reports to the State
    • Emergency Alert Information
    • State of Texas Links
    • Our Cancer Network
    • Vendors & Suppliers
    UT MD Anderson logo
    The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

    © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

    Top